← Leaderboards
Jelani Chinelo Zarif
Johns Hopkins University
$2,205,631
Attributed
$3,395,566
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $852.5K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,395,566 · 3
By mechanism
T32$1,586,580 · 1
R01$1,348,066 · 1
K22$460,920 · 1
Top collaborators
- Elana S Ehrlich4 shared
- Bret A Hassel4 shared
- Michelle Lynn Dykstra Snyder4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Peisong Gao$9,111,293
- Shau-Ku Huang$4,179,464
- Aleksander S. Popel$23,445,364
- Elizabeth Marion Jaffee$29,780,612
- Nilofer S. Azad$4,756,559
Others in their field
Other Emerging Leaders on “Peptides”
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,488,414
- Valerie Fremont · Quality Biological, Inc.$19,261,930
- Lynn Briscoe · Leidos Biomedical Research, Inc.$15,187,907
- Wilton B Williams · Duke University$10,993,477
- Anna Upton · Global Alliance For Tb Drug Development$10,496,979
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$10,496,936
Research focus
PeptidesProgramsIn VivoIn VitroMedicalNeoplastic CellImmune ResponseImmuneInfiltrationInnovationMalignant Neoplasm Of ProstateMannose ReceptorMouse ModelNeoplasm MetastasisCellsCancer CellCheckpoint TherapyGrowthAngiogenesisImmunotherapyAnti-Tumor Immune ResponseCancer PatientMacrophageProstatic Neoplasms
Grant awards (10)
Therapeutic targeting of CD206+ TAMs to enhance adaptive and innate anti-tumor immune responses in metastatic castration-resistant prostate cancer$455,893
R01 · FY2025 · CA · contact PI
Bridges to the Doctorate at Towson University$395,176
T32 · FY2025 · GM
Therapeutic targeting of CD206+ TAMs to enhance adaptive and innate anti-tumor immune responses in metastatic castration-resistant prostate cancer$434,649
R01 · FY2024 · CA · contact PI
Bridges to the Doctorate at Towson University$408,303
T32 · FY2024 · GM
Therapeutic targeting of CD206+ TAMs to enhance adaptive and innate anti-tumor immune responses in metastatic castration-resistant prostate cancer$457,524
R01 · FY2023 · CA · contact PI
Bridges to the Doctorate at Towson University$394,972
T32 · FY2023 · GM
Bridges to the Doctorate at Towson University$388,129
T32 · FY2022 · GM
Targeting M2-Tumor Associated Macrophages to overcome tumor immunity in metastatic castration-resistant prostate cancer$153,640
K22 · FY2021 · CA · contact PI
Targeting M2-Tumor Associated Macrophages to overcome tumor immunity in metastatic castration-resistant prostate cancer$153,640
K22 · FY2020 · CA · contact PI
Targeting M2-Tumor Associated Macrophages to overcome tumor immunity in metastatic castration-resistant prostate cancer$153,640
K22 · FY2019 · CA · contact PI